-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.O2.6 603. Lymphoid Oncogenesis: Basic: Molecular Insights into Lymphomas and CLL

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, Translational Research, Lymphomas, Non-Hodgkin lymphoma, CHIP, Assays, CLL, B Cell lymphoma, Genomics, Bioinformatics, Education, T Cell lymphoma, Hematopoiesis, Diseases, Indolent lymphoma, Cell expansion, Aggressive lymphoma, Immunology, Lymphoid Malignancies, Biological Processes, Emerging technologies, Molecular biology, Technology and Procedures, Gene editing, Multi-systemic interactions, Pathogenesis, Imaging, Molecular testing
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
Moderators:
Darko Barisic, and Panagiotis Ntziachristos, PhD, Ghent University
Disclosures:
No relevant conflicts of interest to declare.
Focus on oncogenesis of non hodgkin lymphomas
9:30 AM

Antonio Ferreira, PhD1, Shumei Wang, MSc2*, Larysa Poluben, MD, PhD3*, Joshua D Brandstadter, MD, PhD, MSc4, Eric Perkey, MD, PhD5, Steven Sotirakos6*, Mai Drew6*, Li Pan6*, Madeleine Lemieux7*, David Dorfman, MD, PhD8, Brent Shoji6*, Ivan Maillard, MD, PhD9, Steve Blacklow10* and Jon C. Aster, MD, PhD11

1Harvard Medical School/ Brigham and Women’s Hospital, Boston, MA
2Brigham and Women’s Hospital, Boston, MA
3Beth Israel Deaconess Medical Center, Boston
4Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, SWARTHMORE, PA
5University of Chicago, Chicago
6Brigham and Women's Hospital, Boston, MA
7Bioinfo, Plantagenet, ON, CAN
8Brigham & Women's Hospital, Boston, MA
9Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
10Dana-Faber Cancer Institute, Boston, MA
11Brigham and Women's Hosp., Boston, MA

9:45 AM

Laura Wiegand1*, Patricia Silva1*, Daniel Noerenberg1*, Friederike Christen1*, Marlon Tilgner1*, Robert Altwasser1*, Klara Kopp1*, Benjamin N. Locher1*, Pelle F. Löwe1*, Catarina M. Stein1*, Vanessa Storzer1*, Franziska Briest1*, Jana Ihlow2*, Anna Dolnik1*, Naveed Ishaque3*, Ulrich Keller1,4*, Livius Penter, MD1,4, Lars Bullinger1,4, Raphael Hablesreiter1* and Frederik Damm1,4*

1Department of Hematology, Oncology, and Cancer Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
2Institute of Pathology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
3Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany
4German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

10:00 AM

Zhangliang Cheng, BSc1*, Kohei Kume, PhD1*, Vignesh Shanmugam, MD2 and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2Broad Institute of MIT and Harvard, Cambridge, MA

10:15 AM

Mike Fernandez, BS1,2, Lei Yu, PhD3*, Qiong Jia, MS3*, Xuesong Wang, MS3*, Kevyn Hart, BS4, Zhenyu Jia, PhD3*, Ren-Jang Lin, PhD5* and Lili Wang, MD, PhD4

1Irell & Manella Graduate School of Biological Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA
2Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA
3Department of Botany and Plant Sciences, University of California Riverside, Riverside, CA
4Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA
5Center for RNA Biology & Therapeutics, City of Hope Comprehensive Cancer Hospital, Duarte, CA

10:30 AM

Chuanjiang Yu, PhD1*, Mara Holloman1*, Andrew Kim1*, Yunchao Chang, PhD2*, Antony Holmes, PhD, BSc, MSc1*, Bowen Cai1*, Stefanie N Meyer, PhD1*, Katia Basso, PhD1*, Govind Bhagat, MD3, Riccardo Dalla-Favera, MD1,3,4,5,6, Charles G. Mullighan, MBBS, MSc, MD2 and Laura Pasqualucci, MD1,3,6

1Institute for Cancer Genetics, Columbia University, New York, NY
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
3Department of Pathology & Cell Biology, Columbia University, New York, NY
4Department of Microbiology & Immunology, Columbia University, New York, NY
5Department of Genetics & Development, Columbia University, New York
6Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

10:45 AM

Longhui Zeng, PhD1*, Xinyan Zhang2*, Yiwei Xiong2*, Nicole Hajicek3*, John Sondek3* and Xiaolei Su2,4*

1Department of Cell Biology, Yale University, New Haven, CT
2Department of Cell Biology, Yale School of Medicine, New Haven, CT
3Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
4Yale Cancer Center, Yale University, New Haven, CT

*signifies non-member of ASH